A FREE report on upcoming FDA decision for small cap company's Pain drug

FDA decision date coming up this month for small cap company's Pain drug. If the FDA approves the drug, the peak sales could reach over 200% of the company's current market cap. Given the mechanism of action, the road to approval perhaps may not be as smooth for this company. To read about our opinion on whether the drug will be approved or not, as well as other important info about the drug, the mechanism of action, the disease, etc., get a FREE REPORT at: h t t p: / / w w w. N e w B i o m e d i c i n e . c o m